Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Biologics for severe asthma have known side effects, but some new risks need more study.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Ammonium bisulfite in hair bleach can cause facial eczema.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.